IU Health Joe and Shelly Schwarz Cancer Center
Carmel, Indiana, United States
Cancer treatment center in Carmel, Indiana
11645 N Illinois St, Carmel, IN 46032
About IU Health Joe and Shelly Schwarz Cancer Center
"Get leading-edge cancer care in Carmel at IU Health Schwarz Cancer Center. Learn how we provide advanced diagnostic and personalized treatment for many cancers."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Indiana University
6
Bristol-Myers Squibb
2
Infinity Pharmaceuticals, Inc.
1
NSABP Foundation Inc
1
R-Pharm
1
US Oncology Research
1
Clinical Trials at IU Health Joe and Shelly Schwarz Cancer Center
During the past decade, IU Health Joe and Shelly Schwarz Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
2008-05-01
2010-08-01
Completed
176
Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic
2008-08-01
2014-06-01
Completed
120
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
2008-09-01
2014-01-01
Completed
100
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
2009-05-01
2018-02-01
Completed
1,613
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
2011-05-01
2014-04-01
Completed
226
Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members
2021-09-13
2023-12-30
Suspended
60
Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)
2021-06-04
2023-08-11
Recruiting
220
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "IU Health Joe and Shelly Schwarz Cancer Center" #1 sponsor was "Indiana University" with 6 trials, followed by "Bristol-Myers Squibb" with 2 trials
sponsored, "Infinity Pharmaceuticals, Inc." with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "R-Pharm"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "IU Health Joe and Shelly Schwarz Cancer Center"
#1 collaborator was "US Oncology Research" with 3 trials as a collaborator, "Breast Cancer Research Foundation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at IU Health Joe and Shelly Schwarz Cancer Center
According to Clinical.Site data, the most researched conditions in "IU Health Joe and Shelly Schwarz Cancer Center" are
"Metastatic Breast Cancer" (3 trials), "Breast Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "BRCA1 Mutation" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "IU Health Joe and Shelly Schwarz Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at IU Health Joe and Shelly Schwarz Cancer Center
Most popular intervention types in "IU Health Joe and Shelly Schwarz Cancer Center" are "Drug" (7 trials), "Behavioral" (2 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Dasatinib" (2 trials), "Ixabepilone" (2 trials), "44 doses of radiation" (1 trials), "54 doses of radiation" (1 trials) and "COVID-19 Vaccination" (1 trials). Other intervention names were less common.
Clinical Trials Genders at IU Health Joe and Shelly Schwarz Cancer Center
The vast majority of trials in "IU Health Joe and Shelly Schwarz Cancer Center" are
8 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at IU Health Joe and Shelly Schwarz Cancer Center
Currently, there are NaN active trials in "IU Health Joe and Shelly Schwarz Cancer Center".
1 are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in IU Health Joe and Shelly Schwarz Cancer Center,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in IU Health Joe and Shelly Schwarz Cancer Center, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".